[Purified human IgG administration, after chemotherapy, to patients with colorectal carcinoma].
The authors, in the present study try to test the prophylactic effect of human IgG on surgical patients affected by colorectal cancer and undergoing chemotherapy in order to prevent microbial infections, supporting immunological host defences.
Faraone
V
V
Cattedra di Chirurgia Generale, Università di Messina.
Arsena
A
A
De Pasquale
M C
MC
Palmisano
M
M
Cottone
G
G
Pione
G
G
Di Mauro
F
F
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control*
D000970:Antineoplastic Agents; D016756:Immunoglobulins, Intravenous
La somministrazione, dopo chemioterapia, di IgG umane purificate in pazienti affetti da carcinoma del colon-retto.